SlideShare uma empresa Scribd logo
1 de 22
Rencontres Interventionnelles - Transradial Approach
                                         Prague, Czech Republic,
                           Thursday 29th & Friday 30th September 2011




     Use	
  of	
  addi*onal	
  morphological	
  and	
  func*onal	
  technics	
  by	
  TRA	
  




Gérard Finet MD PhD!
Department of Cardiology and Interventional Cardiology	

Cardiovascular Hospital - Hospices Civils de Lyon	

                          gerard.finet@univ-­‐lyon1.fr	
  
INSERM Unit 1086	

Claude Bernard University Lyon 1	

Lyon - France
Diagnos*c	
  assessment	
  of	
  atherosclero*c	
  coronary	
  artery	
  lesion	
  

                                        Morphological	
  assessment	
                                  Func*onal	
  assessment	
  

                                MLA	
  <	
  3mm2	
                             %DS	
  >	
  50%	
  
                                      IVUS	
                                    X-­‐ray	
  Angio	
  




                                                                                                                        FFR	
  



                                        VH®	
                                        OCT	
  

                                                                                                       Gould	
  et	
  al.	
  AJC	
  1974	
  
                                                                                                       Takagi	
  et	
  al.	
  Circula8on	
  1999	
  

                                                                                                       Koo	
  et	
  al.	
  
                                                                                                       JACC	
  Cardiovasc	
  Interv	
  2011	
  
                                                                                                       Rioufol	
  &	
  Finet	
  	
  
                                                                                                       JACC	
  Cardiovasc	
  Interv	
  2011	
  	
  

Thim	
  et	
  al.	
  Circula8on	
  -­‐	
  Cardiovasc	
  Imaging	
  2010.	
  
Transradial	
  approaches	
  

          Morphological	
  assessment	
                    Func*onal	
  assessment	
  


6F	
     IVUS	
                     X-­‐ray	
  Angio	
          5-­‐6F	
  



                                                                        FFR	
  



                               6F	
      OCT	
  
Algorithms	
  for	
  the	
  complementary	
  use	
  of	
  FFR	
  and	
  IVUS	
  
Arguments	
  for	
  morphological	
  approaches	
  
IVUS	
  or	
  OCT	
  
View	
  1	
  



View	
  2	
  (orthogonal	
  to	
  view	
  1)	
  




                Coronary	
  angiography	
  


                                                           reference	
     stenosis	
  


                  Cross-­‐sec8onal	
  images	
  

                                IVUS	
  
                    (90	
  µm	
  @	
  30	
  im/sec)	
  




                    Cross-­‐sec8onal	
  images	
  

                                 OCT	
  
                      (13	
  µm	
  @	
  5	
  im/sec)	
  
ACC/AHA/SCAI	
  2005	
  Guideline	
  Update	
  for	
  PCI.	
  	
  
Indica*ons	
  for	
  IVUS	
                                                                                            Circula8on.	
  2005;113:156-­‐175	
  



1-­‐	
  To	
  assess	
  adequacy	
  of	
  coronary	
  stent	
  deployment	
                                                          Class	
  IIa	
   LoE:	
  B	
  
2-­‐	
  To	
  determine	
  the	
  cause	
  of	
  stent	
  restenosis	
  and	
  guide	
  PCI	
  strategy	
                            Class	
  IIa	
   LoE:	
  B	
  
3-­‐	
  To	
  evaluate	
  ambiguous	
  coronary	
  obstrucFon	
                                                                      Class	
  IIa	
   LoE:	
  C	
  
4-­‐	
  To	
  assess	
  a	
  subopFmal	
  angiographic	
  result	
  aHer	
  PCI	
                                                    Class	
  IIa	
   LoE:	
  C	
  
5-­‐	
  To	
  establish	
  the	
  presence	
  and	
  distribuFon	
  of	
  calcium	
  in	
  case	
  of	
  RA	
                        Class	
  IIa	
   LoE:	
  C	
  
6-­‐	
  To	
  determine	
  plaque	
  burden	
  and	
  circumferenFal	
  distribuFon	
  in	
  case	
  of	
  DCA	
   Class	
  IIa	
   LoE:	
  B	
  



                   Acute	
  stent	
  strut	
  	
                               Spontaneous	
  	
  
                                                                               intra-­‐adven**a	
  haematoma	
  
                    malapposiFon	
  
Impact	
  of	
  IVUS	
  guidance	
  on	
  long-­‐term	
  mortality	
  	
  
                                        in	
  sten*ng	
  for	
  unprotected	
  LM	
  coronary	
  artery	
  stenosis	
  

                             Kaplan-­‐Meier	
  incidences	
  curves	
  of	
  outcomes	
  following	
  IVUS	
  and	
  angiograpic	
  guidances	
  




             In	
  201	
  propensity-­‐matched	
  pairs	
  	
                                          In	
  145	
  propensity-­‐matched	
  pairs	
  
                    of	
  the	
  overall	
  populaLon	
                                                       	
  of	
  paLents	
  receiving	
  DES	
  

Park	
  SJ	
  et	
  al.	
  Circ	
  Cardiovasc	
  Intervent	
  2009;	
  2:167-­‐177.	
  

Roy	
  et	
  al.	
  EHJ	
  2008	
  
Hong	
  et	
  al.	
  EHJ	
  2006	
  
Okabe	
  et	
  al.	
  AJC	
  2007	
  
Kim	
  et	
  al.	
  AJC	
  2010	
  
Arguments	
  for	
  func*onal	
  approach	
  
FFR	
  determinaLon	
  by	
  pressure	
  guide	
  
Complex	
  rela*onships	
  between	
  lesion	
  morphology	
  and	
  fluid	
  dynamics	
  




                                               Gould	
  KL.	
  JACC	
  Cardiovasc	
  Imaging	
  2009;2:1009	
  



Raphael	
  Lancet	
  1989	
  
Gould	
  JACC	
  1990	
  
White	
  NEJM	
  1984	
  
Meijboom	
  JACC	
  2008	
  
Gould	
  JACC	
  2009	
  
Erbel	
  EHJ	
  1996	
  	
  	
  	
  	
  	
  
Determination of FFR by pressure guide	
  




                                0.80	
  
                                	
  
                                0.75	
  




                                    Pijls NHJ. Heart 1998; 80:539-542.	

                             Pijls NHJ. Circulation 1995;92:3183-3193.	

                           Matsuo H. Circulation 2002;105:1060-1065.	

                          Bech GJW. Circulation 2001;103:2928-2934.	

                        Bech GJW. J Am Coll Cardiol 1998;31:841-847.	

                         Pijls NHJ. N Engl J Med 1996;334:1703-1708.
Angiographic	
  Versus	
  Func*onal	
  Severity	
  of	
  Coronary	
  Artery	
  Stenoses	
  	
  



DEFER	
  Study	
                                 FAME	
  Study	
  




 325	
  lesions	
                                    1329	
  lesions	
  




                                                                                   Bech	
  et	
  al.	
  Circula8on	
  2001	
  
                                                                                      Tonino	
  et	
  al.	
  JACC	
  2010	
  
FFR	
  and	
  mul*-­‐vessel	
  disease:	
  FAME	
  study’s	
  backfire	
  




                      angiographic	
  
                       func*onal	
  
                                                                  Tonino	
  et	
  al.	
  JACC	
  2010	
  
Mul*vessel	
  disease	
  and	
  diagnosis	
  Spect	
  performances	
  vs	
  FFR	
  




                                                                                                 Concordance	
  42%	
  

                                                                                                  overes*ma*on	
  22%	
  
                                                                                                 underes*ma*on	
  36%	
  




          67	
  pts	
  2-­‐	
  ou	
  3-­‐vx	
  disease	
                                   Ragosta	
  et	
  al.	
  Am	
  J	
  Cardiol	
  2007	
  
                                                                                        Jung	
  et	
  al.	
  Eur	
  Heart	
  J	
  2008;29:2536	
  
                                                                                           Beleslin	
  et	
  al.	
  J	
  Nucl	
  Cardiol	
  2010	
  
Melikian	
  et	
  al.	
  JACC	
  Intv	
  2010;3:307	
                                                          Förster	
  et	
  al.	
  IJCV	
  2010	
  
Topol	
  et	
  al.	
  Circula8on	
  1993	
  
Algorithms	
  for	
  the	
  complementary	
  use	
  of	
  FFR	
  and	
  IVUS	
  
Topol	
  et	
  al.	
  Circula8on	
  1993	
  
Lin	
  et	
  al.	
  JAMA	
  2008	
                                             No	
  previous	
  stress	
  tes*ng	
  
Park	
  et	
  al.	
  Circula8on	
  2011	
  
                                                                                                                                                  Anatomical	
  
                                                                                                        CA	
                                      ambiguity	
  ?	
         IVUS	
  (OCT)	
  

                                                                          Physician	
  esFmate	
  of	
  diagnosis	
  CAD	
  

                                                                                            For	
  each	
  artery	
  

                                                                           no	
       Func8onal	
  ambiguity	
                          yes	
  
                                                                                        (%D	
  stenosis	
  30%	
  -­‐	
  90%)	
  

                                             no	
                                     yes	
  
                                                      %D	
  Sténose	
  >	
  90%	
  


                              %D	
  Sténose	
  <	
  30%	
  

                                                                                                                                                                                 FFR	
  
                     no	
           Consider	
                 yes	
  
                              diffuse	
  ATS	
  lesions*	
  
                                “artery	
  effect“	
  ?	
  


                                                                 FFR	
  

                                                                                                            Consider	
  
          No	
  func*onal	
  	
                          Consider	
                                     RevascularisaLon	
                                                 Consider	
  
                 CAD	
                                 Medical	
  therapy	
                                  	
  w/o	
  FFR	
                                          RevascularisaLon	
  


                                                                                                                                    IVUS-­‐guiding	
  if	
  complex	
  PCI	
  
De	
  Bruyne	
  et	
  al.	
  Circula8on	
  2001*	
  
Jung	
  et	
  al.	
  EHJ	
  2008	
  
Melikian	
  et	
  al.	
  JACC	
  Interv	
  2010	
  
Förster	
  et	
  al.	
  JCI	
  2009	
                                      Previous	
  posi*ve	
  stress	
  tes*ng	
  	
  
Beleslin	
  et	
  al.	
  J	
  Nucl	
  Cardiol	
  2010	
  
Ragosta	
  et	
  al.	
  Am	
  J	
  Cardiol	
  2007	
  
Vigna	
  et	
  al.	
  IJC	
  2005	
  
Lewis	
  et	
  al.	
  AHJ	
  2005	
                                                                                           Anatomical	
  
                                                                                                 CA	
                         ambiguity	
  ?	
                                 IVUS	
  (OCT)	
  
Ashley	
  et	
  al.	
  Lancet	
  2000	
  
Hung	
  et	
  al.	
  JACC	
  1984	
  
Lima	
  et	
  al.	
  JACC	
  2003	
                                    yes	
                                             no	
  
                                                                                   Single	
  coronary	
  disease?	
  

                            no	
                                         yes	
  
                                       %D	
  Sténose	
  >	
  50%	
                                                                        For	
  each	
  artery	
  
                                                                                                                                             %D	
  Stenosis	
  >	
  30%	
  


               If	
  discrepency	
  
        by	
  diffuse	
  ATS	
  lesions	
                                                                                yes	
       Func8onal	
  ambiguity	
                           no	
  
            “artery	
  effect“	
  ?	
                                                                                                    (%D	
  stenosis	
  30%	
  -­‐	
  90%)	
  




                     FFR	
  
                                                                                                                    FFR	
  


                                                                      Consider	
                                                                                                    Consider	
  
            Consider	
                                            RevascularisaLon	
                            Consider	
                                                      RevascularisaLon	
  
          Medical	
  therapy	
                                         	
  w/o	
  FFR	
                     RevascularisaLon	
                                                       	
  w/o	
  FFR	
  



                                                                                                   IVUS-­‐guiding	
  if	
  complex	
  PCI	
  
ACS	
  STEMI/NSTEMI	
  

                                                                                                              Anatomical	
  
Cavender	
  et	
  al.	
  Am	
  J	
  Cardiol	
  2009	
                   CA	
                                  ambiguity	
  ?	
                           IVUS	
  (OCT)	
  




                                                  yes	
                                      no	
  
                                                                Culprit	
  lesion?	
  

                                                                                                                      DetecFon	
  	
  
                                                                                                      of	
  one	
  or	
  more	
  other	
  lesions	
  
                                                                                                                        (>30%)	
  




                                                                                   yes	
                   Func8onal	
  ambiguity	
  	
  	
                no	
  
                                                                                                  (%D	
  stenosis	
  between	
  30%	
  -­‐	
  90%)	
  


                                                                   FFR	
  


             Consider	
                                                                                                                                      Consider	
  
         RevascularisaLon	
                                     Consider	
                                                                               RevascularisaLon	
  	
  
                 w/o	
  FFR	
                               RevascularisaLon	
                                                                                      w/o	
  FFR	
  



                                                                                         IVUS-­‐guiding	
  if	
  complex	
  PCI	
  
Coronary	
  angiography	
  “firstline“:	
  a	
  provoca*ve	
  strategy?	
  
A	
   “convenLonal	
  Bayesian	
  strategy“	
                                                    B	
   “Coronary	
  angiography	
  Firstline“	
  
                                         Clinical	
                                                                              Clinical	
  
                                      presenta*on	
                                                                           Presenta*on*	
  


                                                                                                          no	
               Intermediate	
  or	
  high	
  
                                                                                                                              probability	
  of	
  CAD	
  

                                                                                                                                                                        *Lipinski	
  et	
  al.	
  AHJ	
  2002	
  
                                      Stress	
  tesFng	
                                                                              yes	
                                                                  	
  
                                                                                                                                                                                                             	
  
                                                                                                                                                                                                             	
  
                                                                                                                                                                                                             	
  
                                                                           Stress	
  tesFng	
  (2)	
  
                                                                                                                                                                   **Bugiardini	
  et	
  al.	
  JAMA	
  2005	
  


                                                  CA	
                                                                                     CA	
  
                                                                                                                   (in	
  case	
  of	
  stable	
  coronary	
  lesion)	
                                Class	
  IA	
  
                                                                                                                   FuncFonal	
  ambiguity	
  (%D	
  stenosis	
  30%	
  -­‐	
  90%):	
  	
  FFR	
  
                                                                                                                                                                                       Class	
  IIa/b	
  (B/C)	
  
                                                                                                                                  Anatomical	
  ambiguity	
  :	
  IVUS	
  

                                                                                                                             Angiographically	
  normal	
  arteries	
  :	
  

                                                                                                                                  Vascular	
  func*on	
  study**	
  

                       Consider	
  revascularisa*on	
  	
                                                             Consider	
  revascularisa*on	
  	
  
                                   or	
  OMT	
                                                                                    or	
  OMT	
  
Finet	
  G	
  &	
  Rioufol	
  G.	
  Arch	
  Cardiovasc	
  Dis	
  2011	
  in	
  press	
  	
  
The	
  “oculo-­‐steno*c	
  reflex“	
  will	
  die	
  in	
  2001...	
  
	
  
     	
   	
   	
   	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  ...	
  it	
  will	
  be	
  burried	
  in	
  2011	
  !	
  
	
  
	
  
                                                                      	
  Persan	
  “radialist“	
  interven8onal	
  cardiologist	
  (280	
  BC)	
  

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Abdelaal E - AIMRADIAL 2014 Technical - Local complications
Abdelaal E - AIMRADIAL 2014 Technical - Local complicationsAbdelaal E - AIMRADIAL 2014 Technical - Local complications
Abdelaal E - AIMRADIAL 2014 Technical - Local complications
 
Tizon-Marcos et al
Tizon-Marcos et alTizon-Marcos et al
Tizon-Marcos et al
 
Ikari Y - AIMRADIAL 2015 - Carotid artery stenting
Ikari Y - AIMRADIAL 2015 - Carotid artery stentingIkari Y - AIMRADIAL 2015 - Carotid artery stenting
Ikari Y - AIMRADIAL 2015 - Carotid artery stenting
 
Quesada R
Quesada RQuesada R
Quesada R
 
Wang S
Wang SWang S
Wang S
 
Bernat I - AIMRADIAL 2014 - Slender techniques in Europe
Bernat I - AIMRADIAL 2014 - Slender techniques in EuropeBernat I - AIMRADIAL 2014 - Slender techniques in Europe
Bernat I - AIMRADIAL 2014 - Slender techniques in Europe
 
Jaffe R
Jaffe RJaffe R
Jaffe R
 
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian interventionRuzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
Ruzsa Z - AIMRADIAL 2015 - Radial access for subclavian intervention
 
Bernat I 201111
Bernat I 201111Bernat I 201111
Bernat I 201111
 
Tizon-Marcos et al
Tizon-Marcos et alTizon-Marcos et al
Tizon-Marcos et al
 
Porto I - AIMRADIAL 2014 - Bleeding and events
Porto I - AIMRADIAL 2014 - Bleeding and eventsPorto I - AIMRADIAL 2014 - Bleeding and events
Porto I - AIMRADIAL 2014 - Bleeding and events
 
Biederman DM - AIMRADIAL 2014 Endovascular - Surefire catheter
Biederman DM - AIMRADIAL 2014 Endovascular - Surefire catheterBiederman DM - AIMRADIAL 2014 Endovascular - Surefire catheter
Biederman DM - AIMRADIAL 2014 Endovascular - Surefire catheter
 
Romagnoli E - AIMRADIAL 2013 - Radial and IABP
Romagnoli E - AIMRADIAL 2013 - Radial and IABPRomagnoli E - AIMRADIAL 2013 - Radial and IABP
Romagnoli E - AIMRADIAL 2013 - Radial and IABP
 
Benamer H
Benamer HBenamer H
Benamer H
 
Van Leeuwen M - AIMRADIAL 2015 - Upper limb function
Van Leeuwen M - AIMRADIAL 2015 - Upper limb functionVan Leeuwen M - AIMRADIAL 2015 - Upper limb function
Van Leeuwen M - AIMRADIAL 2015 - Upper limb function
 
Sweis R 2016 Complications of radial access
Sweis R 2016 Complications of radial accessSweis R 2016 Complications of radial access
Sweis R 2016 Complications of radial access
 
Louvard Y - AIMRADIAL 2014 - Sheathless
Louvard Y - AIMRADIAL 2014 - SheathlessLouvard Y - AIMRADIAL 2014 - Sheathless
Louvard Y - AIMRADIAL 2014 - Sheathless
 
Cohen MG - AIMRADIAL 2014 Technical - Tortuosity
Cohen MG - AIMRADIAL 2014 Technical - TortuosityCohen MG - AIMRADIAL 2014 Technical - Tortuosity
Cohen MG - AIMRADIAL 2014 Technical - Tortuosity
 
Ort M - AIMRADIAL 2013 - Nursing perspective
Ort M - AIMRADIAL 2013 - Nursing perspectiveOrt M - AIMRADIAL 2013 - Nursing perspective
Ort M - AIMRADIAL 2013 - Nursing perspective
 
Bertrand OF - AIMRADIAL 2013 - Radial in 100%?
Bertrand OF - AIMRADIAL 2013 - Radial in 100%?Bertrand OF - AIMRADIAL 2013 - Radial in 100%?
Bertrand OF - AIMRADIAL 2013 - Radial in 100%?
 

Destaque

Recent developments in the treatment of atherosclerosis
Recent developments in the treatment of  atherosclerosisRecent developments in the treatment of  atherosclerosis
Recent developments in the treatment of atherosclerosisYasaswini Palukuru
 
8. atherosclerosis
8. atherosclerosis8. atherosclerosis
8. atherosclerosisAhmad Hamadi
 
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMNewer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMDeepak Arjun
 
Coronary lesion assessment
Coronary lesion assessmentCoronary lesion assessment
Coronary lesion assessmentUday Prashant
 
Future of cardiology
Future of cardiologyFuture of cardiology
Future of cardiologymkocierz
 
Devices and technology in interventional cardiology
Devices and technology in interventional cardiologyDevices and technology in interventional cardiology
Devices and technology in interventional cardiologyRamachandra Barik
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiologySuraj Bhorkar
 
The 10 Mistakes I've made...so you don't have to
The 10 Mistakes I've made...so you don't have toThe 10 Mistakes I've made...so you don't have to
The 10 Mistakes I've made...so you don't have toTara Hunt
 

Destaque (19)

Faurie B
Faurie BFaurie B
Faurie B
 
Bernat I
Bernat IBernat I
Bernat I
 
Halkin A
Halkin AHalkin A
Halkin A
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Recent developments in the treatment of atherosclerosis
Recent developments in the treatment of  atherosclerosisRecent developments in the treatment of  atherosclerosis
Recent developments in the treatment of atherosclerosis
 
Kandzari DE 201305
Kandzari DE 201305Kandzari DE 201305
Kandzari DE 201305
 
Cafri C
Cafri CCafri C
Cafri C
 
8. atherosclerosis
8. atherosclerosis8. atherosclerosis
8. atherosclerosis
 
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RMNewer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
Newer advancements in interventional cardiology by DEEPAK ARJUN, RN,RM
 
Coronary lesion assessment
Coronary lesion assessmentCoronary lesion assessment
Coronary lesion assessment
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Future of cardiology
Future of cardiologyFuture of cardiology
Future of cardiology
 
Cohen MG
Cohen MGCohen MG
Cohen MG
 
Left main stenting
Left main stentingLeft main stenting
Left main stenting
 
Devices and technology in interventional cardiology
Devices and technology in interventional cardiologyDevices and technology in interventional cardiology
Devices and technology in interventional cardiology
 
Atherosclerosis 3
Atherosclerosis 3Atherosclerosis 3
Atherosclerosis 3
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiology
 
The 10 Mistakes I've made...so you don't have to
The 10 Mistakes I've made...so you don't have toThe 10 Mistakes I've made...so you don't have to
The 10 Mistakes I've made...so you don't have to
 

Semelhante a Finet G

State of the art mitral valve repair
State of the art mitral valve repairState of the art mitral valve repair
State of the art mitral valve repairdrmaisano
 
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivasDr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivasSociedad Española de Cardiología
 
Multimodality imaging.
Multimodality imaging.Multimodality imaging.
Multimodality imaging.drucsamal
 
Endovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceEndovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceGeorge Trellopoulos
 
Coronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewCoronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewAmir Kraitzer
 
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)European School of Oncology
 
BT FFR .pptx
BT FFR .pptxBT FFR .pptx
BT FFR .pptxgursel2
 
A technical modification of carotid endarterectomy experience with 400 pati...
A technical modification of carotid endarterectomy   experience with 400 pati...A technical modification of carotid endarterectomy   experience with 400 pati...
A technical modification of carotid endarterectomy experience with 400 pati...uvcd
 
121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteries121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteriesSHAPE Society
 
182 non invasive coronary angiography
182 non invasive coronary angiography182 non invasive coronary angiography
182 non invasive coronary angiographySHAPE Society
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.cardiositeindia
 

Semelhante a Finet G (20)

State of the art mitral valve repair
State of the art mitral valve repairState of the art mitral valve repair
State of the art mitral valve repair
 
Urban P
Urban PUrban P
Urban P
 
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivasDr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
 
Multimodality imaging.
Multimodality imaging.Multimodality imaging.
Multimodality imaging.
 
Endovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceEndovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experience
 
Cardio TC in tutti i pazienti con dolore toracico? (PRO)
Cardio TC in tutti i pazienti con dolore toracico? (PRO)Cardio TC in tutti i pazienti con dolore toracico? (PRO)
Cardio TC in tutti i pazienti con dolore toracico? (PRO)
 
Coronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewCoronary Stent - Part A - Overview
Coronary Stent - Part A - Overview
 
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
 
BT FFR .pptx
BT FFR .pptxBT FFR .pptx
BT FFR .pptx
 
19 Ruzsa aimradial20170922 Valvuloplasty BAV
19 Ruzsa aimradial20170922 Valvuloplasty BAV19 Ruzsa aimradial20170922 Valvuloplasty BAV
19 Ruzsa aimradial20170922 Valvuloplasty BAV
 
Aeha muller 2
Aeha muller 2Aeha muller 2
Aeha muller 2
 
A technical modification of carotid endarterectomy experience with 400 pati...
A technical modification of carotid endarterectomy   experience with 400 pati...A technical modification of carotid endarterectomy   experience with 400 pati...
A technical modification of carotid endarterectomy experience with 400 pati...
 
121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteries121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteries
 
121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteries121 non invasive imaging of coronary arteries
121 non invasive imaging of coronary arteries
 
16 FFR Curzen N aimradial2016 - FFR-CT future
16 FFR Curzen N aimradial2016 - FFR-CT future16 FFR Curzen N aimradial2016 - FFR-CT future
16 FFR Curzen N aimradial2016 - FFR-CT future
 
Esv2n41
Esv2n41Esv2n41
Esv2n41
 
182 non invasive coronary angiography
182 non invasive coronary angiography182 non invasive coronary angiography
182 non invasive coronary angiography
 
182 non invasive coronary angiography
182 non invasive coronary angiography182 non invasive coronary angiography
182 non invasive coronary angiography
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stentingRuzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
 

Mais de International Chair on Interventional Cardiology and Transradial Approach

Mais de International Chair on Interventional Cardiology and Transradial Approach (20)

PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
 
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses GalazPCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
 
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
 
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
 
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo BernatPCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
 
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán RuzsaPCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
 
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
 
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
 
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
 
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim NolanPCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
 
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
 
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C GilchristPCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
 
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C GilchristPCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
 
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. BertrandPCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
 
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
 
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
 
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
 
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. FearonPCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
 
PCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin BerryPCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin Berry
 
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
 

Último

Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Último (20)

Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

Finet G

  • 1. Rencontres Interventionnelles - Transradial Approach Prague, Czech Republic, Thursday 29th & Friday 30th September 2011 Use  of  addi*onal  morphological  and  func*onal  technics  by  TRA   Gérard Finet MD PhD! Department of Cardiology and Interventional Cardiology Cardiovascular Hospital - Hospices Civils de Lyon gerard.finet@univ-­‐lyon1.fr   INSERM Unit 1086 Claude Bernard University Lyon 1 Lyon - France
  • 2. Diagnos*c  assessment  of  atherosclero*c  coronary  artery  lesion   Morphological  assessment   Func*onal  assessment   MLA  <  3mm2   %DS  >  50%   IVUS   X-­‐ray  Angio   FFR   VH®   OCT   Gould  et  al.  AJC  1974   Takagi  et  al.  Circula8on  1999   Koo  et  al.   JACC  Cardiovasc  Interv  2011   Rioufol  &  Finet     JACC  Cardiovasc  Interv  2011     Thim  et  al.  Circula8on  -­‐  Cardiovasc  Imaging  2010.  
  • 3. Transradial  approaches   Morphological  assessment   Func*onal  assessment   6F   IVUS   X-­‐ray  Angio   5-­‐6F   FFR   6F   OCT  
  • 4. Algorithms  for  the  complementary  use  of  FFR  and  IVUS  
  • 5. Arguments  for  morphological  approaches   IVUS  or  OCT  
  • 6. View  1   View  2  (orthogonal  to  view  1)   Coronary  angiography   reference   stenosis   Cross-­‐sec8onal  images   IVUS   (90  µm  @  30  im/sec)   Cross-­‐sec8onal  images   OCT   (13  µm  @  5  im/sec)  
  • 7. ACC/AHA/SCAI  2005  Guideline  Update  for  PCI.     Indica*ons  for  IVUS   Circula8on.  2005;113:156-­‐175   1-­‐  To  assess  adequacy  of  coronary  stent  deployment   Class  IIa   LoE:  B   2-­‐  To  determine  the  cause  of  stent  restenosis  and  guide  PCI  strategy   Class  IIa   LoE:  B   3-­‐  To  evaluate  ambiguous  coronary  obstrucFon   Class  IIa   LoE:  C   4-­‐  To  assess  a  subopFmal  angiographic  result  aHer  PCI   Class  IIa   LoE:  C   5-­‐  To  establish  the  presence  and  distribuFon  of  calcium  in  case  of  RA   Class  IIa   LoE:  C   6-­‐  To  determine  plaque  burden  and  circumferenFal  distribuFon  in  case  of  DCA   Class  IIa   LoE:  B   Acute  stent  strut     Spontaneous     intra-­‐adven**a  haematoma   malapposiFon  
  • 8. Impact  of  IVUS  guidance  on  long-­‐term  mortality     in  sten*ng  for  unprotected  LM  coronary  artery  stenosis   Kaplan-­‐Meier  incidences  curves  of  outcomes  following  IVUS  and  angiograpic  guidances   In  201  propensity-­‐matched  pairs     In  145  propensity-­‐matched  pairs   of  the  overall  populaLon    of  paLents  receiving  DES   Park  SJ  et  al.  Circ  Cardiovasc  Intervent  2009;  2:167-­‐177.   Roy  et  al.  EHJ  2008   Hong  et  al.  EHJ  2006   Okabe  et  al.  AJC  2007   Kim  et  al.  AJC  2010  
  • 9. Arguments  for  func*onal  approach   FFR  determinaLon  by  pressure  guide  
  • 10. Complex  rela*onships  between  lesion  morphology  and  fluid  dynamics   Gould  KL.  JACC  Cardiovasc  Imaging  2009;2:1009   Raphael  Lancet  1989   Gould  JACC  1990   White  NEJM  1984   Meijboom  JACC  2008   Gould  JACC  2009   Erbel  EHJ  1996            
  • 11. Determination of FFR by pressure guide   0.80     0.75   Pijls NHJ. Heart 1998; 80:539-542. Pijls NHJ. Circulation 1995;92:3183-3193. Matsuo H. Circulation 2002;105:1060-1065. Bech GJW. Circulation 2001;103:2928-2934. Bech GJW. J Am Coll Cardiol 1998;31:841-847. Pijls NHJ. N Engl J Med 1996;334:1703-1708.
  • 12. Angiographic  Versus  Func*onal  Severity  of  Coronary  Artery  Stenoses     DEFER  Study   FAME  Study   325  lesions   1329  lesions   Bech  et  al.  Circula8on  2001   Tonino  et  al.  JACC  2010  
  • 13. FFR  and  mul*-­‐vessel  disease:  FAME  study’s  backfire   angiographic   func*onal   Tonino  et  al.  JACC  2010  
  • 14. Mul*vessel  disease  and  diagnosis  Spect  performances  vs  FFR   Concordance  42%   overes*ma*on  22%   underes*ma*on  36%   67  pts  2-­‐  ou  3-­‐vx  disease   Ragosta  et  al.  Am  J  Cardiol  2007   Jung  et  al.  Eur  Heart  J  2008;29:2536   Beleslin  et  al.  J  Nucl  Cardiol  2010   Melikian  et  al.  JACC  Intv  2010;3:307   Förster  et  al.  IJCV  2010  
  • 15. Topol  et  al.  Circula8on  1993  
  • 16. Algorithms  for  the  complementary  use  of  FFR  and  IVUS  
  • 17. Topol  et  al.  Circula8on  1993   Lin  et  al.  JAMA  2008   No  previous  stress  tes*ng   Park  et  al.  Circula8on  2011   Anatomical   CA   ambiguity  ?   IVUS  (OCT)   Physician  esFmate  of  diagnosis  CAD   For  each  artery   no   Func8onal  ambiguity   yes   (%D  stenosis  30%  -­‐  90%)   no   yes   %D  Sténose  >  90%   %D  Sténose  <  30%   FFR   no   Consider   yes   diffuse  ATS  lesions*   “artery  effect“  ?   FFR   Consider   No  func*onal     Consider   RevascularisaLon   Consider   CAD   Medical  therapy    w/o  FFR   RevascularisaLon   IVUS-­‐guiding  if  complex  PCI   De  Bruyne  et  al.  Circula8on  2001*  
  • 18. Jung  et  al.  EHJ  2008   Melikian  et  al.  JACC  Interv  2010   Förster  et  al.  JCI  2009   Previous  posi*ve  stress  tes*ng     Beleslin  et  al.  J  Nucl  Cardiol  2010   Ragosta  et  al.  Am  J  Cardiol  2007   Vigna  et  al.  IJC  2005   Lewis  et  al.  AHJ  2005   Anatomical   CA   ambiguity  ?   IVUS  (OCT)   Ashley  et  al.  Lancet  2000   Hung  et  al.  JACC  1984   Lima  et  al.  JACC  2003   yes   no   Single  coronary  disease?   no   yes   %D  Sténose  >  50%   For  each  artery   %D  Stenosis  >  30%   If  discrepency   by  diffuse  ATS  lesions   yes   Func8onal  ambiguity   no   “artery  effect“  ?   (%D  stenosis  30%  -­‐  90%)   FFR   FFR   Consider   Consider   Consider   RevascularisaLon   Consider   RevascularisaLon   Medical  therapy    w/o  FFR   RevascularisaLon    w/o  FFR   IVUS-­‐guiding  if  complex  PCI  
  • 19. ACS  STEMI/NSTEMI   Anatomical   Cavender  et  al.  Am  J  Cardiol  2009   CA   ambiguity  ?   IVUS  (OCT)   yes   no   Culprit  lesion?   DetecFon     of  one  or  more  other  lesions   (>30%)   yes   Func8onal  ambiguity       no   (%D  stenosis  between  30%  -­‐  90%)   FFR   Consider   Consider   RevascularisaLon   Consider   RevascularisaLon     w/o  FFR   RevascularisaLon   w/o  FFR   IVUS-­‐guiding  if  complex  PCI  
  • 20. Coronary  angiography  “firstline“:  a  provoca*ve  strategy?  
  • 21. A   “convenLonal  Bayesian  strategy“   B   “Coronary  angiography  Firstline“   Clinical   Clinical   presenta*on   Presenta*on*   no   Intermediate  or  high   probability  of  CAD   *Lipinski  et  al.  AHJ  2002   Stress  tesFng   yes           Stress  tesFng  (2)   **Bugiardini  et  al.  JAMA  2005   CA   CA   (in  case  of  stable  coronary  lesion)   Class  IA   FuncFonal  ambiguity  (%D  stenosis  30%  -­‐  90%):    FFR   Class  IIa/b  (B/C)   Anatomical  ambiguity  :  IVUS   Angiographically  normal  arteries  :   Vascular  func*on  study**   Consider  revascularisa*on     Consider  revascularisa*on     or  OMT   or  OMT   Finet  G  &  Rioufol  G.  Arch  Cardiovasc  Dis  2011  in  press    
  • 22. The  “oculo-­‐steno*c  reflex“  will  die  in  2001...                                                                          ...  it  will  be  burried  in  2011  !        Persan  “radialist“  interven8onal  cardiologist  (280  BC)